MedPath

TOPICAL 40% TCA (TRICHLOROACETIC ACID) WITH NEEDLING VERSUS NEEDLING ALONE IN THE MANAGEMENT OF PLANTAR WARTS

Not Applicable
Completed
Conditions
Health Condition 1: B070- Plantar wart
Registration Number
CTRI/2018/12/016510
Lead Sponsor
Armed Forces Medical College Pune
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

All patients (18-60 yrs) with plantar warts attending Dermatology OPD in a tertiary care hospital in western Maharashtra.

Exclusion Criteria

1) Consent Denial.

2) Un-cooperative patients

3) Previous history of hypersensitivity to TCA

4) Known case of HIV/HBsAg/HCV/Diabetes

Or Bleeding disorder

5) Patients who have taken treatment for

plantar warts in the last one month

6) Age less than 18yrs or more than 60yrs

7)Immunosuppressed patient

(On immunosuppressants or daily/pulse steroids)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the efficacy of topical 40% TCA (trichloroacetic acid) with needling versus needling alone in complete cure/ improvement of the plantar warts. <br/ ><br> <br/ ><br>Resolution as defined based on:- Reduction in size and/or number/clearance of the warts as marked by the patient & the dermatologist <br/ ><br>1)Complete cure: 100% clearance of warts (return of normal dermatoglyphics) <br/ ><br>2)Mild resolution: Upto 50% improvement <br/ ><br>3)Moderate resolution: 50-99.9% improvement <br/ ><br>Timepoint: After 12 weeks of therapy
Secondary Outcome Measures
NameTimeMethod
1. To compare the time taken for clinical cure/ improvement of the plantar warts <br/ ><br>2. To observe for any adverse effects of needling & topical 40% TCA application <br/ ><br>Timepoint: At 4-weekly intervals and after 12 weeks of therapy
© Copyright 2025. All Rights Reserved by MedPath